The steady growth of mirtazapine

Use of mirtazapine in aged care facilities has been steadily growing – but is it always appropriate? This is part one of a focus on the use of antipsychotics and other medicines of concern in residential aged care. The Pharmaceutical Benefits Advisory Committee is set to investigate the use of antipsychotics in Australia, following a

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Reducing polypharmacy deaths
Next CAPS makes ‘casual Friday’ call